Shulyak Alexander, Gorpynchenko Igor, Drannik George, Poroshina Tatiana, Savchenko Viktoria, Nurimanov Kamil
State Institution "Institute of Urology of National Academy of Medical Sciences of Ukraine", Kiev, Ukraine.
Cent European J Urol. 2019;72(1):66-70. doi: 10.5173/ceju.2018.1719. Epub 2019 Jan 10.
Chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS) is a complex medical problem. Comorbid depression and chronic pain are highly prevalent in individuals suffering with chronic abacterial prostatitis (CAP) perhaps due to the direct or indirect effects of cytokines. Cytokines interact with the neuronal environment, and thus modulation of the duration of inflammation may alleviate depressive and pain symptoms. The aim of our study was to evaluate the effectiveness of combination of rectal electrostimulation and a selective serotonin reuptake inhibitor, sertraline, in the treatment of patients with chronic abacterial prostatitis and to determine the dynamics and links of pro-inflammatory and anti-inflammatory cytokine levels in the ejaculate.
The interrelation of CP/CPPS symptoms, depression and cytokines in patients with CAP was studied. For the assessment of severity of CP/CPPS the National Institutes of Health (NIH)-Chronic Prostatitis Symptom Index (CPSI) was used. For the assessment of depression, the Patient Health Questionnaire-9 (PHQ-9) was used. The levels of cytokines [Interleukin (IL)-1β (IL-1β), IL-8, IL-10, tumor necrosis factor-alpha (TNF-α) and transforming growth factor-β1 (TGF-β1)] in semen were assessed by ELISA (Diaclon, DRG, Ukrmedservice). All enrolled patients (n = 81) with CAP aged 19 to 38 years received basic treatment with rectal electrostimulation every other day for 10 sessions lasting 15 minutes each. Patients in Group 1 (n = 42) who additionally received oral sertraline with an initial dose of 50 mg gradually being increased to 200 mg were treated for 1 month. Patients in Group 2 (n = 39) received basic treatment only. Distribution of patients was random. All the statistical analyses were performed using SPSS.
The data from patients in Group 1 and Group 2 demonstrated that after treatment, a statistically significant (p <0.05) decrease in the concentration of pro-inflammatory cytokines (TNF-α, IL-1β, IL-8) in ejaculate was observed. At the same time, there was a significant increase (p <0.05) in the content of anti-inflammatory cytokines (IL-10 and TGF-β1) in Group 1 only. Clinical efficacy of combined treatment of patients with CP/CPPS was 83% in Group 1 and 62% in Group 2 compared to the symptoms of prostatitis, and 76% in Group 1 and 41% in Group 2 compared to the symptoms of depressive disorders.
The results demonstrate the effectiveness (83%) of the combination of rectal electrostimulation and an antidepressant (sertraline) in the treatment of CAP, and also show the role of neuro-immune regulation and its disorders (including depressive disorders) in the pathogenesis of СAP.
慢性前列腺炎/慢性盆腔疼痛综合征(CP/CPPS)是一个复杂的医学问题。合并抑郁症和慢性疼痛在慢性非细菌性前列腺炎(CAP)患者中非常普遍,这可能是由于细胞因子的直接或间接作用。细胞因子与神经环境相互作用,因此调节炎症持续时间可能会减轻抑郁和疼痛症状。我们研究的目的是评估直肠电刺激与选择性5-羟色胺再摄取抑制剂舍曲林联合治疗慢性非细菌性前列腺炎患者的有效性,并确定精液中促炎和抗炎细胞因子水平的动态变化及关联。
研究了CAP患者中CP/CPPS症状、抑郁症和细胞因子之间的相互关系。使用美国国立卫生研究院(NIH)慢性前列腺炎症状指数(CPSI)评估CP/CPPS的严重程度。使用患者健康问卷9(PHQ-9)评估抑郁症。通过酶联免疫吸附测定(ELISA,Diaclon、DRG、Ukrmedservice)评估精液中细胞因子[白细胞介素(IL)-1β(IL-1β)、IL-8、IL-10、肿瘤坏死因子-α(TNF-α)和转化生长因子-β1(TGF-β1)]的水平。所有纳入研究的年龄在19至38岁之间的CAP患者(n = 81)每隔一天接受一次直肠电刺激基础治疗,共10次,每次持续15分钟。第1组(n = 42)患者额外口服舍曲林,初始剂量为50 mg,逐渐增加至200 mg,治疗1个月。第2组(n = 39)患者仅接受基础治疗。患者随机分组。所有统计分析均使用SPSS进行。
第1组和第2组患者的数据表明,治疗后,精液中促炎细胞因子(TNF-α、IL-1β、IL-8)的浓度出现统计学显著下降(p <0.05)。同时,仅在第1组中抗炎细胞因子(IL-10和TGF-β1)的含量显著增加(p <0.05)。与前列腺炎症状相比,CP/CPPS患者联合治疗的临床有效率在第1组为83%,在第2组为62%;与抑郁症症状相比,在第1组为76%,在第2组为41%。
结果表明直肠电刺激与抗抑郁药(舍曲林)联合治疗CAP有效(83%),并显示了神经免疫调节及其紊乱(包括抑郁症)在CAP发病机制中的作用。